One thing people don't talk about enough with $HIMS is the YourBio acquisition. Hims Labs was nice but nothing special—clean UI, easy results, AI help. Nice perks. The real game-changer? YourBio. Preventative healthcare's biggest hurdle isn't access, it's friction. People put i
Heading into this sell-off, big tech stocks were packed tight with investors. Like I always say, when everyone's crammed on one side of the boat, it's bound to tip over.
Breaking now: Central banks are sitting on more gold than they have since the year 2000 🏆
That’s a massive shift from the early 2000s when they were selling it off. Times have changed.
The biggest IPO ever is finally happening this week 🚀
Here's the full catalyst rundown I just shared with my free daily newsletter subscribers
Brace yourselves for what's coming ⬇️⬇️⬇️⬇️
@victory16889 Interesting timing. A lot of people are betting big on AI infrastructure right now, but I wonder if consumer demand will actually keep up with all that spending.
@ciou1603 That's a massive drop. Makes me wonder if they're trying to attract a wave of smaller investors before the valuation gets tricky. I'd still read the fine print carefully.
CleanSpark just hit its first Golden Cross since July 2025 🚨 Last time, the stock shot up over 90% in just three months ✅ Think $CLSK is ready for another run? Check out the Tradr 2X Long CLSK Daily ETF $CLSX from @TradrETFs for amplified exposure
@viy88520 Makes sense when you think about how much compute and talent these models eat up. Public money is the next logical step when VC appetite has limits.
Building AI is getting crazy expensive. Daniela Amodei (co-founder of Anthropic) says that's why companies like hers are turning to public markets for funding. 💸 No surprise there.